----item----
version: 1
id: {15817550-ECE8-4FC7-8E83-6E695A3DACD3}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/Mergers and Acquisitions 2012
parent: {D5B965D3-AC3D-4A7F-90E6-65193022C6B5}
name: Mergers and Acquisitions 2012
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: b544c28a-f61e-4c3f-a139-320e147af2eb

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 1162

<p>  <tbody> <tr> </tr> <tr> <td> <tbody> <tr> <td>The latest medtech deals, as and when it happens<a></a><br> <em>By Madeleine Armstrong, Editor, Business</em><br> In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its &lsquo;live&rsquo; M&amp;A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2012 so far. </td> </tr> <tr> <td><strong>M&amp;A 2012</strong></td> <td><a><strong>M&amp;A 2011</strong></a></td> <td><strong><a>M&amp;A 2010</a></strong></td> <td><strong><a>FREE TRIAL</a></strong></td> </tr> </tbody> </td> </tr> <tr> <td><a></a></td> <td><div><a></a></div></td> <td><a></a></td> <td><div><a></a></div></td> <td><a></a></td> <td><a></a></td> <td><a></a></td> <td><a></a></td> </tr> <tr> <td><div><a>Deals</a></div></td> <td><div><a>M&amp;A </a></div></td> <td><div><a>Financials</a></div></td> <td><div><a>Funding </a></div></td> <td><div><a>Legal</a></div></td> <td><div><a>Start-ups &amp; SMEs </a></div></td> <td><div><a>Market Monitor </a></div></td> <td><div><a>Google Map: M&amp;A 2010 </a></div></td> </tr> </tbody>  </p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 29

Mergers and Acquisitions 2012
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 87918

<p> <table> <tbody> <tr> </tr> <tr> <td colspan="8" scope="row" widtd="101"><table> <tbody> <tr> <td colspan="4" scope="row" widtd="101">The latest medtech deals, as and when it happens<a name="top" id="top"></a><br> <em>By Madeleine Armstrong, Editor, Business</em><br> In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its &lsquo;live&rsquo; M&amp;A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2012 so far. </td> </tr> <tr> <td bgcolor="#cccccc" scope="row" widtd="101"><strong>M&amp;A 2012</strong></td> <td bgcolor="#666666" scope="row" widtd="101"><a href="http://www.clinica.co.uk/MnA/_2011/" class="optionsLink"><strong>M&amp;A 2011</strong></a></td> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/MnA/_2010/" class="optionsLink">M&amp;A 2010</a></strong></td> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/freetrial/" class="optionsLink">FREE TRIAL</a></strong></td> </tr> </tbody> </table></td> </tr> <tr> <td><a href="http://www.clinica.co.uk/business/"><img src="-/media/A41DB0E6789340E3BBE2BB586EBE4293.ashx" alt="Deals" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/manda/"><img src="-/media/1594690D6C314ABFA668C2F281D90DEC.ashx" alt="M&amp;A" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></div></td> <td><a href="http://www.clinica.co.uk/business/financials/"><img src="-/media/873669F6772642DC9C0C091A39B44486.ashx" alt="Financials" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><div><a href="http://www.clinica.co.uk/business/funding/"><img src="-/media/B1AB1227A20C433897DB3C8B2F140E45.ashx" alt="Funding" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></div></td> <td><a href="http://www.clinica.co.uk/business/legal/"><img src="-/media/7D0516FC157A4E1F896F543962188904.ashx" alt="Legal" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/business/start-upssmes/"><img src="-/media/66EE0878ED2E4CEC9D21449351C40077.ashx" alt="Start-ups &amp; SMEs" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/business/marketmonitor/"><img src="-/media/808B4B2204F542438455FA3DB83F4C28.ashx" alt="Market Monitor" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/ma2/"><img src="-/media/7183F022AB364B8C8C43E7EC13518288.ashx" alt="Google Map" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> </tr> <tr> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/" class="optionsLink">Deals</a></div></td> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/manda/" class="optionsLink">M&amp;A </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/financials/" class="optionsLink">Financials</a></div></td> <td><div><a href="http://www.clinica.co.uk/business/funding/" class="optionsLink">Funding </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/legal/" class="optionsLink">Legal</a></div></td> <td><div><a href="http://www.clinica.co.uk/business/start-upssmes/" class="optionsLink">Start-ups &amp; SMEs </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/marketmonitor/" class="optionsLink">Market Monitor </a></div></td> <td><div><a href="http://www.clinica.co.uk/ma2/" class="optionsLink">Google Map: M&amp;A 2010 </a></div></td> </tr> </tbody> </table> </p> <p><p> <table> <tr> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Acquirer </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Target </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Industry sector </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Price paid </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Date announced </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Date completed </b> </p> </th> </tr> <tr> <td> <p> <b>2012 </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> </tr> <tr> <td> <p> <b>DECEMBER</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>RadNet (US)</b> </p> </td> <td> <p> Lenox Hill Radiology (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> $30.3m </p> </td> <td><p></td> <td> <p> 31/12/2012 </p> </td> </tr> <tr> <td> <p> <b>Access Genetics (US)</b> </p> </td> <td> <p> Quest Diagnostic's OralDNA Labs subsidiary (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Quest-sells-saliva-diagnostics-business-as-it-continues-streamlining-338714">31/12/2012</a> </p> </td> </tr> <tr> <td> <p> <b>DJO (US)</b> </p> </td> <td> <p> Exos (US) </p> </td> <td> <p> Orthopaedics (skeletal support and stabilisation) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 31/12/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>BC Technical (US)</b> </p> </td> <td> <p> Genesis Medical Imaging (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 29/12/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Thermo Fisher Scientific (US)</b> </p> </td> <td> <p> picoSpin (US) </p> </td> <td> <p> Chemical analysis (spectroscopy) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Thermo-Fisher-boosts-chemical-analysis-business-with-picoSpin-purchase-338600">28/12/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Halma (UK)</b> </p> </td> <td> <p> MicroSurgical Technology (US) </p> </td> <td> <p> Ophthalmology </p> </td> <td> <p> $57m upfront, $43m milestones </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Halma-continues-ophthalmic-focus-with-MicroSurgical-acquisition-338598?autnID=/contentstore/clinica/codex/edf2a7ed-50e2-11e2-87fb-f1a3e14bcfeb.xml">28/12/2012</a> </p> </td> </tr> <tr> <td> <p> <b>AssuraMed (US)</b> </p> </td> <td> <p> Invacare's medical supplies business (US) </p> </td> <td> <p> Medical supplies for chronic conditions </p> </td> <td> <p> $150m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Invacare-offloads-medical-supplies-business-to-reduce-complexity-338565?autnID=/contentstore/clinica/codex/ea93297c-501e-11e2-87fb-f1a3e14bcfeb.xml">27/12/2012</a> </p> </td> <td> <p> 18/1/2013 </p> </td> </tr> <tr> <td> <p> <b>Covidien (US)</b> </p> </td> <td> <p> CV Ingenuity (US) </p> </td> <td> <p> Cardiovascular (drug-coated balloon for peripheral arterial disease) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Covidien-gains-drug-coated-balloon-tech-for-PAD-with-CV-Ingenuity-buy-338564?autnID=/contentstore/clinica/codex/357105bc-5019-11e2-87fb-f1a3e14bcfeb.xml">27/12/2012</a> </p> </td> <td> <p> 10/1/2013 </p> </td> </tr> <tr> <td> <p> <b>OPKO Health (US)</b> </p> </td> <td> <p> Silcon Com√©rcio (Brazil) </p> </td> <td> <p> Pharmaceuticals </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 26/12/2012 </p> </td> <td> <p> 15/2/2013 </p> </td> </tr> <tr> <td> <p> <b>Dako (Denmark)</b> </p> </td> <td> <p> Intellectual property from System Dynamics (US) </p> </td> <td> <p> Laboratory information system connectivity software </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 21/12/2012 </p> </td> </tr> <tr> <td> <p> <b>Kinetic Concepts (US)</b> </p> </td> <td> <p> MoMelan Technologies (US) </p> </td> <td> <p> Wound care (skin grafting) </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Kinetic-Concepts-diversifies-into-skin-grafting-with-MoMelan-buy-338481?autnID=/contentstore/clinica/codex/e4cfeef5-4abe-11e2-87fb-f1a3e14bcfeb.xml">20/12/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Ambu (Denmark)</b> </p> </td> <td> <p> Consort Medical's King Systems unit (UK) </p> </td> <td> <p> Anaesthesia, emergency care and patient monitoring </p> </td> <td> <p> $120m upfront and $50m milestones </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Consort-makes-sensible-move-to-divest-devices-unit-to-focus-on-faster-growing-drug-delivery-338482?autnID=/contentstore/clinica/codex/344e3faf-4ab7-11e2-87fb-f1a3e14bcfeb.xml">20/12/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Crawford Healthcare (UK)</b> </p> </td> <td> <p> HiMedica (UK) </p> </td> <td> <p> Skin and woundcare </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Crawford-boosts-RandD-capabilities-with-HiMedica-buy-338426?autnID=/contentstore/clinica/codex/8bacebea-49e5-11e2-87fb-f1a3e14bcfeb.xml">19/12/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Bio-Rad Laboratories (US)</b> </p> </td> <td> <p> MorphoSys's AbD Serotec business (Germany) </p> </td> <td> <p> Research and diagnostic antibodies </p> </td> <td> <p> &euro;53m ($70m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Morphosys-offloads-Dx-unit-to-Bio-Rad-338335?autnID=/contentstore/clinica/codex/09e0cf97-485e-11e2-87fb-f1a3e14bcfeb.xml">17/12/2012</a> </p> </td> <td> <p> 10/1/2013 </p> </td> </tr> <tr> <td> <p> <b>Amgen (US)</b> </p> </td> <td> <p> deCODE Genetics (Iceland) </p> </td> <td> <p> Genome sequencing/molecular diagnostics </p> </td> <td> <p> $415m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Beautiful-baton-pass-as-Amgen-picks-up-deCODE-to-validate-drug-targets-338135?autnID=/contentstore/clinica/codex/e543b303-4375-11e2-87fb-f1a3e14bcfeb.xml">11/12/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Diagnostic Imaging International (US)</b> </p> </td> <td> <p> Schulkyll Open MRI (US) </p> </td> <td> <p> Diagnostic imaging (MRI clinic) </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 10/12/2012 </p> </td> </tr> <tr> <td> <p> <b>Baxter International (US)</b> </p> </td> <td> <p> Gambro (Sweden) </p> </td> <td> <p> Haemodialysis products </p> </td> <td> <p> SEK26.5bn ($4bn) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Baxter-pumps-new-life-into-haemodialysis-offering-with-4bn-Gambro-buy-337850?autnID=/contentstore/clinica/codex/7640fab0-3e28-11e2-968f-8d7669f37d2e.xml">4/12/2012</a> </p> </td> <td> <p> 6/9/13 </p> </td> </tr> <tr> <td> <p> <b>Volcano (US)</b> </p> </td> <td> <p> Crux Biomedical (US) </p> </td> <td> <p> Peripheral vascular treatment (pulmonary embolisms) </p> </td> <td> <p> $36m plus $3m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Volcano-gets-to-Crux-of-300m-peripheral-embolism-market-with-36m-acquisition-337846?autnID=/contentstore/clinica/codex/e212bfa8-3e19-11e2-968f-8d7669f37d2e.xml">4/12/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Trivitron (India)</b> </p> </td> <td> <p> Ani Labsystems (Finland) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> &euro;15.8m ($20.6m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Trivitrons-Finnish-Dx-buy-underscores-trend-of-emerging-players-going-global-337831?autnID=/contentstore/clinica/codex/cb9ab3c5-3d69-11e2-968f-8d7669f37d2e.xml">3/12/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cretex Companies (US)</b> </p> </td> <td> <p> Spectralytics (US) </p> </td> <td> <p> Contract medtech manufacturing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 3/12/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Merit Medical Systems (US)</b> </p> </td> <td> <p> Medigroup (US) </p> </td> <td> <p> Peritoneal dialysis catheter </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Merit-swells-bottom-line-for-coming-year-with-double-whammy-buy-337734?autnID=/contentstore/clinica/codex/778cb633-3b0d-11e2-968f-8d7669f37d2e.xml">3/12/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Merit Medical Systems (US)</b> </p> </td> <td> <p> Thomas Medical Products (US) </p> </td> <td> <p> Catheter-based vascular access delivery devices </p> </td> <td> <p> $167m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Merit-swells-bottom-line-for-coming-year-with-double-whammy-buy-337734?autnID=/contentstore/clinica/codex/778cb633-3b0d-11e2-968f-8d7669f37d2e.xml">3/12/2012</a> </p> </td> <td> <p> 20/12/2012 </p> </td> </tr> <tr> <td> <p> <b>NOVEMBER</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Smith &amp; Nephew (UK)</b> </p> </td> <td> <p> Healthpoint Biotherapeutics (US) </p> </td> <td> <p> Bioactives (wound healing) </p> </td> <td> <p> $782m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/SandN-splashes-out-782m-on-Healthpoint-to-enter-bioactives-market-337666?autnID=/contentstore/clinica/codex/7441a62d-3a20-11e2-968f-8d7669f37d2e.xml">29/11/2012</a> </p> </td> <td> <p> 24/12/2012 </p> </td> </tr> <tr> <td> <p> <b>Sorin (Italy)</b> </p> </td> <td> <p> Minority stake in HighLife SAS (France) </p> </td> <td> <p> Cardiovascular (transcatheter mitral valve replacement) </p> </td> <td> <p> &euro;4.2m ($5.4m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Sorin-secures-option-to-buy-in-mitral-valve-start-up-HighLife-with-4.2m-minority-stake-337588?autnID=/contentstore/clinica/codex/12463c69-38a8-11e2-968f-8d7669f37d2e.xml">28/11/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Bayer (Germany)</b> </p> </td> <td> <p> Radimetrics (Canada) </p> </td> <td> <p> Healthcare software (radiation dose measurement) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 26/11/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Volcano (US)</b> </p> </td> <td> <p> Sync-Rx (Israel) </p> </td> <td> <p> Software applications (optimising and facilitating transcatheter cardiovascular interventions) </p> </td> <td> <p> $17.3m </p> </td> <td> <p> 23/11/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Alcon (US)</b> </p> </td> <td> <p> SensoMotoric Instruments' ophthalmic division (Germany) </p> </td> <td> <p> Ophthalmology (surgical guidance technology) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Alcon-strengthens-cataract-surgery-offering-buying-SensoMotorics-ophthalmic-division-337441">22/11/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Wright Medical (US)</b> </p> </td> <td> <p> BioMimetic Therapeutics (US) </p> </td> <td> <p> Orthopaedics (regenerative medicine) </p> </td> <td> <p> $190m upfront plus milestones of up to $190m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Wright-Medical-buys-BioMimetic-to-ramp-up-orthobiologics-growth-337414">21/11/2012</a> </p> </td> <td> <p> 1/3/2013 </p> </td> </tr> <tr> <td> <p> <b>Westhouse Medical Services (UK)</b> </p> </td> <td> <p> Quy Biosciences (UK) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> &pound;3.25m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Westhouse-moves-into-regenerative-medicine-with-Quy-majority-stake-337357">19/11/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Skanray Healthcare (India)</b> </p> </td> <td> <p> Larsen &amp; Toubro's medical equipment business (India) </p> </td> <td> <p> Diagnostic imaging and primary healthcare devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 16/11/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>BioTime (US)</b> </p> </td> <td> <p> Geron's stem cell offering (US) </p> </td> <td> <p> Stem cell therapy </p> </td> <td> <p> $5m in cash, $30m in BioTime common stock, warrants to purchase eight million BioTime shares </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Geron-sells-stem-cells-by-the-seashore-in-structured-deal-with-BioTime-337297?autnID=/contentstore/clinica/codex/a13af771-2fd2-11e2-968f-8d7669f37d2e.xml">16/11/2012</a> </p> </td> <td> <p> 1/10/13 </p> </td> </tr> <tr> <td> <p> <b>Nihon Kohden (Japan)</b> </p> </td> <td> <p> Defibtech (US) </p> </td> <td> <p> Automated external defibrillators </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/11/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sorin (Italy)</b> </p> </td> <td> <p> Neurotech (Belgium) </p> </td> <td> <p> Neuromodulation devices </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Sorin-to-speed-development-of-heart-failure-neuromodulation-with-Neurotech-purchase-337195?autnID=/contentstore/clinica/codex/9bb30931-2dad-11e2-968f-8d7669f37d2e.xml">13/11/2012</a> </p> </td> </tr> <tr> <td> <p> <b>PerkinElmer (US)</b> </p> </td> <td> <p> Shanghai Haoyuan Biotech (China) </p> </td> <td> <p> IVDs (infectious disease testing for blood screening and labs) </p> </td> <td> <p> $38m plus milestones </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/PerkinElmer-expands-Chinese-Dx-offering-further-with-38m-Shanghai-Haoyuan-buy-337174?autnID=/contentstore/clinica/codex/46c54a21-2da3-11e2-968f-8d7669f37d2e.xml">13/11/2012</a> </p> </td> </tr> <tr> <td> <p> <b>2IL Orthopaedics (Italy)</b> </p> </td> <td> <p> Corin (UK) </p> </td> <td> <p> Orthopaedics </p> </td> <td> <p> &pound;30.5m ($48m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Corin-to-be-sold-for-30.5m-to-PE-investors-337143?autnID=/contentstore/clinica/codex/9d8e8675-2cf1-11e2-968f-8d7669f37d2e.xml">13/11/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> U-Systems (US) </p> </td> <td> <p> Diagnostic imaging (ultrasound for breast cancer screening) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/GE-gains-new-FDA-approved-3D-us-tech-for-mammo-offering-337144?autnID=/contentstore/clinica/codex/7853513a-2ccd-11e2-968f-8d7669f37d2e.xml">13/11/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Spectrum Brands (US)</b> </p> </td> <td> <p> Shaser Bioscience (US) </p> </td> <td> <p> Aesthetics </p> </td> <td> <p> $50m for 56% stake </p> </td> <td> <p> 12/11/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Bausch + Lomb (US)</b> </p> </td> <td> <p> Technolas Perfect Vision (Germany) </p> </td> <td> <p> Ophthalmology - femtosecond laser for cataract and corneal surgeries </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Bausch--Lomb-buys-joint-venture-Technolas-337009">9/11/2012</a> </p> </td> <td> <p> 28/1/2013 </p> </td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> Vessix Vascular (US) </p> </td> <td> <p> Renal denervation </p> </td> <td> <p> $125m upfront and $300m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Bostons-Vessix-buy-pits-it-against-Medtronic-St-Jude-in-renal-denervation-market-337000">9/11/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Endeavour Capital (US)</b> </p> </td> <td> <p> Access Scientific (US) </p> </td> <td> <p> IV catheters </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 7/11/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Exonhit Therapeutics (France)</b> </p> </td> <td> <p> InGen Biosciences (France) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> &euro;18m ($23m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/New-IVD-player-Diaxonhit-emerges-from-Exonhits-InGen-purchase-336919">7/11/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sparton (US)</b> </p> </td> <td> <p> Onyx EMS (US) </p> </td> <td> <p> OEM devices including cardiovascular and point-of-care diagnostics, hearing assistance, surgical equipment </p> </td> <td> <p> $43.25m </p> </td> <td> <p> 6/11/2012 </p> </td> <td> <p> 19/11/2012 </p> </td> </tr> <tr> <td> <p> <b>Life Technologies (UK)</b> </p> </td> <td> <p> Advanced Microscopy Group (US) </p> </td> <td> <p> Imaging systems for research microscopy </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/11/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Caresteam Health (US)</b> </p> </td> <td> <p> Genesis Digital Imaging (US) </p> </td> <td> <p> Imaging software </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/11/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>SRS Medical (US)</b> </p> </td> <td> <p> AbbeyMoor Medical's Spanner prostatic stent </p> </td> <td> <p> Urology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/11/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>OCTOBER</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>McKesson (US)</b> </p> </td> <td> <p> PSS World Medical (US) </p> </td> <td> <p> Medical product distribution </p> </td> <td> <p> $2.1 billion including debt </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/McKesson-looks-for-100m-synergies-with-2.1bn-PSS-buy-336697">30/10/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Agenix (Australia)</b> </p> </td> <td> <p> Diagnostic technology from Tyrian (Australia) </p> </td> <td> <p> Point-of-care diagnostics platform </p> </td> <td> <p> Shares to the value of $.05m </p> </td> <td> <p> 25/10/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CR Bard (US)</b> </p> </td> <td> <p> Neomend (US) </p> </td> <td> <p> Surgical sealants </p> </td> <td> <p> $140m upfront plus $25m in milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Bard-enters-1bn-surgical-sealant-market-with-Neomend-buy-336524?autnID=/contentstore/clinica/codex/51354ba4-1df0-11e2-968f-8d7669f37d2e.xml">24/10/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>OPKO Health (US)</b> </p> </td> <td> <p> Prost-Data (aka OURLab, US) </p> </td> <td> <p> CLIA lab - IVDs for prostate cancer </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 19/10/2012 </p> </td> <td> <p> 18/12/2012 </p> </td> </tr> <tr> <td> <p> <b>Steris (US)</b> </p> </td> <td> <p> Total Repair Express (US) </p> </td> <td> <p> Surgical instrument repair </p> </td> <td> <p> $110m for Spectrum and Total Repair Excess together </p> </td> <td> <p> 19/10/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Steris (US)</b> </p> </td> <td> <p> Spectrum Surgical Instruments (US) </p> </td> <td> <p> Surgical instrument repair </p> </td> <td> <p> $110m for Spectrum and Total Repair Excess together </p> </td> <td> <p> 19/10/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CD Diagnostics (US)</b> </p> </td> <td> <p> 80% of Citrano Medical Laboratories (US) </p> </td> <td> <p> Clinical lab testing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 18/10/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Surpass Medical (Israel) </p> </td> <td> <p> Neurology (treatment of brain aneurysms) </p> </td> <td> <p> $100m upfront and up to $35m in milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/neurological/Strykers-Surpass-buy-feeds-growing-neurovasc-unit-pares-down-2012-and-2013-earnings-guidance-336301">18/10/2012</a> </p> </td> <td> <p> 1/11/2012 </p> </td> </tr> <tr> <td> <p> <b>Helix Medical (US)</b> </p> </td> <td> <p> MedVenture Technology (US) </p> </td> <td> <p> OEM manufacture of minimally-invasive and catheter-based devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 17/10/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> LifeTech Scientific (China) </p> </td> <td> <p> Cardiovascular devices </p> </td> <td> <p> $46.6m for a 19% stake initially and $19.6m for 7.4% thereafter </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Medtronic-makes-more-inroads-into-China-with-stake-in-heart-tech-firm-336265">17/10/2012</a> </p> </td> <td> <p> 30/1/2013 </p> </td> </tr> <tr> <td> <p> <b>Quest Diagnostics (US)</b> </p> </td> <td> <p> Clinical outreach lab business of UMass Memorial Medical Center (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 16/10/2012 </p> </td> <td> <p> 2/1/2013 </p> </td> </tr> <tr> <td> <p> <b>The Gores Group (US)</b> </p> </td> <td> <p> Ortho-Clinical Diagnostics' Therakos division (US) </p> </td> <td> <p> Extracorporeal photopheresis (ECP) for treating blood cancer </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/home/news/Gores-offers-to-offload-photopheresis-business-from-JandJs-Dx-unit-336214?autnID=/contentstore/clinica/codex/3cc88e1d-17a7-11e2-bab1-bf1e3606a991.xml">16/10/2012</a> </p> </td> <td> <p> 2/1/2013 </p> </td> </tr> <tr> <td> <p> <b>Edwards Lifesciences (US)</b> </p> </td> <td> <p> BMEYE (the Netherlands) </p> </td> <td> <p> Noninvasive haemodynamic monitoring </p> </td> <td> <p> &euro;32.5m ($42m) </p> </td> <td><p></td> <td> <p> 11/10/2012 </p> </td> </tr> <tr> <td> <p> <b>Life Technologies (UK)</b> </p> </td> <td> <p> Compendia Bioscience (US) </p> </td> <td> <p> Bioinformatics </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/home/news/Life-Technologies-aims-to-be-companion-Dx-partner-of-choice-with-Compendia-acquisition-336016?autnID=/contentstore/clinica/codex/ccd793b0-122b-11e2-bab1-bf1e3606a991.xml">10/10/2012</a> </p> </td> </tr> <tr> <td> <p> <b>CareFusion (US)</b> </p> </td> <td> <p> Intermed (Brazil) </p> </td> <td> <p> Mechanical lung ventilation and anesthesia </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/CareFusion-finds-key-to-Latin-America-and-beyond-in-Brazils-Intermed-335993?autnID=/contentstore/clinica/codex/f44e6657-1223-11e2-bab1-bf1e3606a991.xml">10/10/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> Rhythmia Medical (US) </p> </td> <td> <p> Surgical navigation tools </p> </td> <td> <p> $90m upfront and up to $175m in milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Bostons-latest-265m-buy-of-ablation-guidance-firm-gets-lukewarm-investor-reception-335991?autnID=/contentstore/clinica/codex/0433ebb4-1219-11e2-bab1-bf1e3606a991.xml">10/10/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>AngioDynamics (US)</b> </p> </td> <td> <p> Vortex Medical (US) </p> </td> <td> <p> Devices for the removal of blood clots </p> </td> <td> <p> $15m upfront plus $8m per year for the first five years </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/AngioDynamics-hopes-to-add-50m-to-top-line-in-five-years-with-Vortex-buy-336000?autnID=/contentstore/clinica/codex/b67dd7ef-1220-11e2-bab1-bf1e3606a991.xml">9/10/2012</a> </p> </td> <td> <p> 16/10/2012 </p> </td> </tr> <tr> <td> <p> <b>Given Imaging (Israel)</b> </p> </td> <td> <p> SmartPill's SmartPill GI monitoring system (US) </p> </td> <td> <p> Gastrointestinal monitoring </p> </td> <td> <p> $6m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Given-gets-Smart-with-6m-GI-monitoring-capsule-buy-335810?autnID=/contentstore/clinica/codex/91d4fac3-0ef0-11e2-bab1-bf1e3606a991.xml">5/10/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Erba Diagnostics (Germany)</b> </p> </td> <td> <p> Escalon Medical's clinical diagnostics business (US) </p> </td> <td> <p> In vitro diagnostics and analysers (OEM) </p> </td> <td> <p> $6.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Erba-expands-into-US-with-6.5m-Escalon-Dx-acquisition-335815?autnID=/contentstore/clinica/codex/e481c9f9-0efa-11e2-bab1-bf1e3606a991.xml">5/10/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medivision (Germany)</b> </p> </td> <td> <p> 51% stake in stellacure (Cord Blood America's German subsidiary) </p> </td> <td> <p> Umbilical cord blood stem cell preservations </p> </td> <td> <p> &euro;33,649 ($43,420) </p> </td> <td> <p> 4/10/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Creganna-Tactx (Ireland)</b> </p> </td> <td> <p> ABT Medical (Ireland) </p> </td> <td> <p> Vascular and angioplasty balloons </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/10/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Corpak MedSystems (US)</b> </p> </td> <td> <p> Merck Serono's gastroenterology sales and distribution operation in the UK and Ireland </p> </td> <td> <p> Gastroenterology eg bedside feeding systems </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 2/10/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>B Braun (Germany)</b> </p> </td> <td> <p> Ahlcon Parenterals (India) </p> </td> <td> <p> Intravenous fluids </p> </td> <td> <p> Rs3.31 billion ($63 million) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/B-Braun-buys-63m-parenterals-firm-for-Asian-growth-335617?autnID=/contentstore/clinica/codex/092652c2-0c8b-11e2-bab1-bf1e3606a991.xml">2/10/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>SEPTEMBER</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> Kanghui Medical (China) </p> </td> <td> <p> Orthopaedics (trauma and spine) </p> </td> <td> <p> $816m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Medtronic-buys-Chinese-ortho-firm-as-global-footprint-grows-335523?autnID=/contentstore/clinica/codex/e48ca1f9-0963-11e2-bab1-bf1e3606a991.xml">28/9/2012</a> </p> </td> <td> <p> 1/11/2012 </p> </td> </tr> <tr> <td> <p> <b>Valeant (Canada)</b> </p> </td> <td> <p> QLT's Visudyne light-activated drug (Canada) </p> </td> <td> <p> Ophthalmology - treatment of wet age-related macular degeneration </p> </td> <td> <p> $112.5 million up front and up to $20 million in milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/QLT-sells-superseded-AMD-therapy-Visudyne-to-Valeant-335419?autnID=/contentstore/clinica/codex/7829e558-07b6-11e2-bab1-bf1e3606a991.xml">26/9/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Bruker (US)</b> </p> </td> <td> <p> Carestream Health's preclinical in vivo imaging portfolio (US) </p> </td> <td> <p> Preclinical imaging for animal research </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Bruker-bulks-up-preclinical-imaging-offering-with-Carestream-in-vivo-portfolio-purchase-335342">24/9/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> BridgePoint Medical (US) </p> </td> <td> <p> Treatment of coronary chronic total occlusions (CTOs) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Boston-becomes-CTO-treatment-leader-with-BridgePoint-acquisition-335312?autnID=/contentstore/clinica/codex/e90e799a-03da-11e2-b20f-932a5a4a0848.xml">21/9/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Illumina (US)</b> </p> </td> <td> <p> BlueGnome (UK) </p> </td> <td> <p> Gene sequencing/genetic testing </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Illumina-looks-to-tuck-in-acquisitions-for-growth-as-it-buys-IVF-screening-firm-BlueGnome-335254?autnID=/contentstore/clinica/codex/69a2e521-030c-11e2-b20f-932a5a4a0848.xml">20/9/2012</a> </p> </td> </tr> <tr> <td> <p> <b>BGI-Shenzhen (China)</b> </p> </td> <td> <p> Complete Genomics (US) </p> </td> <td> <p> DNA sequencing </p> </td> <td> <p> $117.6m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Chinas-BGI-gains-US-foothold-with-117m-Complete-Genomics-buy-335177?autnID=/contentstore/clinica/codex/11f9cfbd-00de-11e2-b20f-932a5a4a0848.xml">18/9/2012</a> </p> </td> <td> <p> 18/3/2013 </p> </td> </tr> <tr> <td> <p> <b>Danaher (US)</b> </p> </td> <td> <p> Iris International (US) </p> </td> <td> <p> Urinalysis </p> </td> <td> <p> $338m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Danaher-focuses-on-automated-urine-diagnostics-with-338m-Iris-buy-335141?autnID=/contentstore/clinica/codex/722a8ea1-00d2-11e2-b20f-932a5a4a0848.xml">17/9/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Patterson Dental (US)</b> </p> </td> <td> <p> Iowa Dental Supply (US) </p> </td> <td> <p> Dental supplies and equipment </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 10/9/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ConvaTec (US)</b> </p> </td> <td> <p> 180 Medical (US) </p> </td> <td> <p> Catheters </p> </td> <td> <p> $321m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/ConvaTec-branches-out-into-catheters-with-321m-purchase-of-180-Medical-Holdings-334600?autnID=/contentstore/clinica/codex/09111024-f6a7-11e1-b20f-932a5a4a0848.xml">4/9/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sias (Switzerland)</b> </p> </td> <td> <p> Xiril (Switzerland) </p> </td> <td> <p> Laboratory equipment and related software used for diagnostics and DNA analysis </p> </td> <td> <p> Undiclosed </p> </td> <td> <p> 3/9/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>AUGUST</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Life Time Fitness (US)</b> </p> </td> <td> <p> MGC Diagnostics' New Leaf business (US) </p> </td> <td> <p> Wellness and fitness products </p> </td> <td> <p> $1.24m </p> </td> <td><p></td> <td> <p> 30/8/2012 </p> </td> </tr> <tr> <td> <p> <b>Charles River Laboratories International (US)</b> </p> </td> <td> <p> Accugenix (US) </p> </td> <td> <p> Microbial identification testing for manufacturing of medical devices and biopharmaceuticals </p> </td> <td> <p> $17m </p> </td> <td> <p> 29/8/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Transgenomic (US)</b> </p> </td> <td> <p> Global rights to Axial Biotech's ScoliScore (US) </p> </td> <td> <p> Saliva-based multi-gene test to assess the likelihood of spinal curve progression for adolescents diagnosed with adolescent idiopathic scoliosis </p> </td> <td> <p> $4.4m </p> </td> <td> <p> 28/8/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Agilent Technologies (US)</b> </p> </td> <td> <p> Aurora SFC Systems (US) </p> </td> <td> <p> Supercritical fluid chromatography products </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Agilent-buys-out-long-term-partner-Aurora-to-boost-lab-research-offering-334372?autnID=/contentstore/clinica/codex/9a040015-f126-11e1-b20f-932a5a4a0848.xml">28/8/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Tornier (the Netherlands)</b> </p> </td> <td> <p> OrthoHelix Surgical Designs (US) </p> </td> <td> <p> Orthopaedics - foot and ankle implants </p> </td> <td> <p> $135m plus potential milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Tornier-to-more-than-double-lower-extremity-sales-with-135m-OrthoHelix-buy-334371?autnID=/contentstore/clinica/codex/24439cfb-f11a-11e1-b20f-932a5a4a0848.xml">28/8/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Becton Dickinson (US)</b> </p> </td> <td> <p> Sirigen Group (UK) </p> </td> <td> <p> Polymer dyes for use in flow cytometry </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 27/8/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Siemens Healthcare (Germany)</b> </p> </td> <td> <p> Penrith (US) </p> </td> <td> <p> Miniaturised ultrasound technology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Siemens-eyes-POC-ultrasound-expansion-with-Penrith-buy-334276?autnID=/contentstore/clinica/codex/60063f19-ed1a-11e1-90fa-4f6a396faa73.xml">23/8/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Leica Biosystems (Germany)</b> </p> </td> <td> <p> Aperio (US) </p> </td> <td> <p> Digital pathology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 21/8/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Orchid Medical (US)</b> </p> </td> <td> <p> Surgical implant business from Workers' Implantable Network (US) </p> </td> <td> <p> Medical services - helping with compensation claims for patients with implantable devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 17/8/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Vascular Solutions (US)</b> </p> </td> <td> <p> St Jude Medical's Venture wire control catheter (US) </p> </td> <td> <p> Cardiovascular (coronary and peripheral interventional procedures) </p> </td> <td> <p> $3m ($2.25m upfront and $750,000 on completion) </p> </td> <td> <p> 17/8/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Quintiles (US)</b> </p> </td> <td> <p> Expression Analysis (US) </p> </td> <td> <p> Genomics testing and analysis </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Quintiles-strengthens-personalised-medicine-capabilities-with-Expression-Analysis-buy-334117">17/8/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ConMed (US)</b> </p> </td> <td> <p> Viking Systems (US) </p> </td> <td> <p> Imaging system for use during minimally-invasive surgery </p> </td> <td> <p> $22.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/ConMed-gains-surgical-imaging-tech-with-22.5m-Viking-buy-334088">16/8/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Getinge (Sweden)</b> </p> </td> <td> <p> Kinetic Concepts' Therapeutic Support Systems (US) </p> </td> <td> <p> Pressure ulcer prevention and management </p> </td> <td> <p> $275m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Getinge-buys-Kinetic-Concepts-TSS-unit-to-flesh-out-North-American-woundcare-presence-334051">16/8/2012</a> </p> </td> <td> <p> 8/11/2012 </p> </td> </tr> <tr> <td> <p> <b>Teleflex (US)</b> </p> </td> <td> <p> LMA International (Singapore) </p> </td> <td> <p> Laryngeal masks </p> </td> <td> <p> S$343.5m ($276m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Teleflex-knocks-out-big-bucks-for-laryngeal-mask-leader-to-expand-anaesthesia-334016">15/8/2012</a> </p> </td> <td> <p> 23/10/2012 </p> </td> </tr> <tr> <td> <p> <b>Helix Medical (US)</b> </p> </td> <td> <p> 50% stake in Cambus Medical (Ireland) </p> </td> <td> <p> Hypotubes and micro-component solutions for advanced catheter systems </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/8/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Alphatec Spine (US)</b> </p> </td> <td> <p> Phygen (US) </p> </td> <td> <p> Spinal implants </p> </td> <td> <p> $15.2m </p> </td> <td> <p> 7/8/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CardioNet (US)</b> </p> </td> <td> <p> cardioCORE Lab (US) </p> </td> <td> <p> Cardiac monitoring services </p> </td> <td> <p> $23.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/CardioNet-gets-20m-sales-boost-through-cardioCORE-buy-333597">7/8/2012 </a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>SynenTec (Germany)</b> </p> </td> <td> <p> Roche's Cellavista system (Switzerland) </p> </td> <td> <p> Research - cell analysis </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Roche-further-trims-applied-sciences-offering-with-Cellavista-sale-333594">7/8/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>OPKO Health (US)</b> </p> </td> <td> <p> Farmadiet Group Holding (Spain) </p> </td> <td> <p> Pharmaceutical, nutraceutical and veterinary products </p> </td> <td> <p> &euro;13.5m ($16.8m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/OPKOs-Farmadiet-buy-could-swell-Latin-American-sales-333590">7/8/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Dohmen (US)</b> </p> </td> <td> <p> Reglera (US) </p> </td> <td> <p> Regulatory affairs consulting for the medical device industry </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 2/8/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Masimo (US)</b> </p> </td> <td> <p> Phasein (Sweden) </p> </td> <td> <p> Capnography and gas monitoring </p> </td> <td> <p> $30.4m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Masimo-buys-capnography-specialist-to-inflate-offerings-Q2-profits-barely-rise-333471">2/8/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>JULY</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Novogen (Australia)</b> </p> </td> <td> <p> Kai Medical (US) </p> </td> <td> <p> Sleep apnoea </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Pared-down-Novogen-takes-chance-on-sleep-apnoea-market-with-Kai-reverse-takeover-333392?autnID=/contentstore/clinica/codex/d8bc7143-db15-11e1-90fa-4f6a396faa73.xml">31/7/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Roper Industries (US)</b> </p> </td> <td> <p> Sunquest Information Systems (US) </p> </td> <td> <p> Diagnostic software for hospital labs </p> </td> <td> <p> $1.415bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Roper-Industries-moves-into-diagnostic-software-with-1.4bn-Sunquest-buy-333379?autnID=/contentstore/clinica/codex/24187579-daf9-11e1-90fa-4f6a396faa73.xml">31/7/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Hill-Rom (US)</b> </p> </td> <td> <p> Aspen Surgical Products (US) </p> </td> <td> <p> Surgical consumables </p> </td> <td> <p> $400m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Hill-Rom-diversifies-surgical-portfolio-with-Aspen-deal-333263">27/7/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Fresenius Kabi (Germany)</b> </p> </td> <td> <p> Fenwal (US) </p> </td> <td> <p> Blood transfusion/collection products </p> </td> <td> <p> $1.1bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Fenwal-buy-lets-Fresenius-grab-more-share-of-blood-transfusion-tech-market-333256">26/7/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Life Technologies (UK)</b> </p> </td> <td> <p> Pinpoint Genomics (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 25/7/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Owens &amp; Minor (US)</b> </p> </td> <td> <p> Movianto (Germany) </p> </td> <td> <p> Healthcare third-party logistics (pharma and medical devices) </p> </td> <td> <p> &euro;130m ($163.4m) </p> </td> <td> <p> 23/7/2012 </p> </td> <td> <p> 31/8/2012 </p> </td> </tr> <tr> <td> <p> <b>Medline Industries (US)</b> </p> </td> <td> <p> Key assets of Perrigo's personal hygeine business (US) </p> </td> <td> <p> Personal hygeine products </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 23/7/2012 </p> </td> </tr> <tr> <td> <p> <b>Tecomet (US)</b> </p> </td> <td> <p> Teleflex's OEM orthopaedics business (US) </p> </td> <td> <p> Orthopaedic products </p> </td> <td> <p> $45.2m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Teleflex-further-hones-medtech-focus-with-Hotspur-acquisition-sheds-OEM-orthopaedics-unit-333050">20/7/2012</a> </p> </td> <td> <p> 16/8/2012 </p> </td> </tr> <tr> <td> <p> <b>Teleflex (US)</b> </p> </td> <td> <p> Hotspur Technologies (US) </p> </td> <td> <p> Catheter-based treatments for blockages of peripheral vasculature/dialysis access </p> </td> <td> <p> $15m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Teleflex-further-hones-medtech-focus-with-Hotspur-acquisition-sheds-OEM-orthopaedics-unit-333050">20/7/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Steris (US)</b> </p> </td> <td> <p> US Endoscopy Group (US) </p> </td> <td> <p> GI endoscopy devices </p> </td> <td> <p> $270m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Steris-moves-into-GI-market-with-270m-US-Endoscopy-buy-333039">20/7/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Allezoe Medical Holdings (US)</b> </p> </td> <td> <p> HealthWatch Systems (US) </p> </td> <td> <p> Ovulation monitoring device </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 19/7/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Accuray (US)</b> </p> </td> <td> <p> Morphomics (US) </p> </td> <td> <p> Medical imaging software </p> </td> <td> <p> $5.7m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Accuray-shapes-up-radiotherapy-planning-offering-with-Morphormics-buy-332930?autnID=/contentstore/clinica/codex/096a6530-d00f-11e1-b604-af25a6688b21.xml">18/7/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Thermo Fisher Scientific (US)</b> </p> </td> <td> <p> One Lambda (US) </p> </td> <td> <p> Transplant diagnostics </p> </td> <td> <p> $925m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Thermo-to-buy-transplant-diagnostics-leader-One-Lambda-332877?autnID=/contentstore/clinica/codex/ac1f74f2-cf63-11e1-b604-af25a6688b21.xml">17/7/2012</a> </p> </td> <td> <p> 13/9/2012 </p> </td> </tr> <tr> <td> <p> <b>Life Technologies (UK)</b> </p> </td> <td> <p> Navigenics (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 16/7/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Becton Dickinson (US)</b> </p> </td> <td> <p> Safety Syringes (US) </p> </td> <td> <p> Anti-needlestick devices for prefilled syringes </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 11/7/2012 </p> </td> <td> <p> 26/12/2012 </p> </td> </tr> <tr> <td> <p> <b>Sorin (Italy)</b> </p> </td> <td> <p> Cardiosolutions (US) </p> </td> <td> <p> Percutaneous mitral valve repair </p> </td> <td> <p> $8m for minority stake </p> </td> <td> <p> 11/7/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Unnamed private equity firm (Canada)</b> </p> </td> <td> <p> IBA's Canadian molecular business </p> </td> <td> <p> Imaging agents </p> </td> <td> <p> Can$14.1m ($13.8m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/IBA-back-on-track-to-offload-molecular-imaging-biz-and-focus-on-proton-therapy-332651?autnID=/contentstore/clinica/codex/9c541376-ca9c-11e1-b604-af25a6688b21.xml">10/7/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Luminex (US)</b> </p> </td> <td> <p> GenturaDx (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $50m plus milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Luminex-adds-to-molecular-Dx-offering-further-with-50m-GenturaDx-buy-332588?autnID=/contentstore/clinica/codex/ed64e6fd-c9d7-11e1-b604-af25a6688b21.xml">9/7/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sorin (Italy) </b> </p> </td> <td> <p> California Medical Laboratories (CalMed, US) </p> </td> <td> <p> Cannulae for cardiovascular surgical procedures </p> </td> <td> <p> $14m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Sorin-bolts-on-new-cannulae-line-with-14m-CalMed-buy-332447?autnID=/contentstore/clinica/codex/6c0cbee2-c4fd-11e1-b604-af25a6688b21.xml">3/7/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Asahi Kasei (Japan)</b> </p> </td> <td> <p> ThermoGenesis's (US) CryoSeal </p> </td> <td> <p> Wound care/surgery </p> </td> <td> <p> $2m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/ThermoGenesis-offloads-CryoSeal-to-Asahi-Kasei-to-focus-on-stem-cells-332419?autnID=/contentstore/clinica/codex/5c5c9169-c519-11e1-b604-af25a6688b21.xml">3/7/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Tegal (US) </b> </p> </td> <td> <p> CollabRx (US) </p> </td> <td> <p> Data analytics for genomics-based medicine </p> </td> <td> <p> Share-based deal </p> </td> <td> <p> 2/7/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Linde Group (Germany)</b> </p> </td> <td> <p> Lincare (US) </p> </td> <td> <p> Home respiratory products </p> </td> <td> <p> $4.6bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Linde-raises-1.4bn-to-help-fund-Lincare-purchase-332685">1/7/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>JUNE</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Medifocus (US)</b> </p> </td> <td> <p> Boston Scientific's Prolieve (US) </p> </td> <td> <p> Urology (benign prostatic hyperplasia treatment) </p> </td> <td> <p> $5m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Boston-sells-Prolieve-back-to-originator-for-just-5m-332318">29/6/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Theradiag (France)</b> </p> </td> <td> <p> Prestizia (France) </p> </td> <td> <p> In vitro diagnostics (theranostics) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Frances-Theradiag-makes-maiden-acquisition-to-gain-microRNA-tech-332185">27/6/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Qiagen (the Netherlands)</b> </p> </td> <td> <p> Intelligent Bio-Systems (US) </p> </td> <td> <p> Next-generation genome sequencing </p> </td> <td> <p> $50m? </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Qiagens-Intelligent-Bio-Systems-buy-seen-as-wise-jump-into-genome-sequencing-332141">27/6/2012</a> </p> </td> <td> <p> ? </p> </td> </tr> <tr> <td> <p> <b>Teleflex (US)</b> </p> </td> <td> <p> Semprus BioSciences (US) </p> </td> <td> <p> Antimicrobial device coatings </p> </td> <td> <p> $30m upfront plus up to $50 milestones </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Teleflex-gains-next-gen-coating-tech-with-30m-Semprus-acquisition-332107">26/6/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Precision Spine (US)</b> </p> </td> <td> <p> Spinal USA (US) and Precision Medical (US) - merger </p> </td> <td> <p> Orthopaedics (spinal) </p> </td> <td> <p> $72m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/New-spinal-player-emerges-with-Precision-Medical-and-Spinal-USA-combo-332103">26/6/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Ascom (Switzerland)</b> </p> </td> <td> <p> GE Healthcare's Nurse Call business (US) </p> </td> <td> <p> Hospital communications </p> </td> <td> <p> $22m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/GE-offloads-non-core-Nurse-Call-unit-to-Ascom-331933?autnID=/contentstore/clinica/codex/de20eafc-bae2-11e1-96f7-cb330bbb8023.xml">21/6/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Elekta (Sweden)</b> </p> </td> <td> <p> Radon (Brazil) </p> </td> <td> <p> Linear accelerators for radiotherapy </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Elekta-to-compete-in-Brazilian-multi-million-dollar-linac-tender-bid-with-Radon-buy-331924?autnID=/contentstore/clinica/codex/d6455638-bac4-11e1-96f7-cb330bbb8023.xml">20/6/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Vascular Solutions (US)</b> </p> </td> <td> <p> Radial artery wrist positioning system from Accumed Systems (US) </p> </td> <td> <p> Surgery/imaging (tool for use during radial artery access eg for coronary angiography) </p> </td> <td> <p> $1.5m </p> </td> <td><p></td> <td> <p> 13/6/2012 </p> </td> </tr> <tr> <td> <p> <b>EQT Partners (Sweden)</b> </p> </td> <td> <p> BSN Medical (Germany) </p> </td> <td> <p> Wound care, compression therapy and orthopaedics </p> </td> <td> <p> &euro;1.8bn ($2.25bn) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Private-equity-firm-EQT-wins-1.8bn-bid-for-BSN-331694?autnID=/contentstore/clinica/codex/cba86330-b47c-11e1-96f7-cb330bbb8023.xml">12/6/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CareFusion (US)</b> </p> </td> <td> <p> UK Medical (UK) </p> </td> <td> <p> Interventional technologies (existing UK distributor) </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/CareFusion-strengthens-largest-non-US-market-presence-with-UK-distributor-buy-331634?autnID=/contentstore/clinica/codex/2a70440c-b161-11e1-96f7-cb330bbb8023.xml">11/6/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Mindray Medical International (China)</b> </p> </td> <td> <p> Controlling stake in Dragonbio Surgical Implant (China) </p> </td> <td> <p> Orthopaedics </p> </td> <td> <p> $35.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Chinas-Mindray-diversifies-into-ortho-space-with-Dragonbio-331585?autnID=/contentstore/clinica/codex/c5c8f1fa-b092-11e1-96f7-cb330bbb8023.xml">8/6/2012</a> </p> </td> <td> <p> 19/7/2012 </p> </td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> Xpro (Brazil) </p> </td> <td> <p> Diagnostic imaging (X-ray) </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/GE-intensifies-focus-on-LatAm-market-and-buys-Brazils-Xpro-331587?autnID=/contentstore/clinica/codex/ccc0c6ee-b09f-11e1-96f7-cb330bbb8023.xml">8/6/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Sectra (Sweden)</b> </p> </td> <td> <p> Burnbank Systems (UK) </p> </td> <td> <p> Healthcare IT </p> </td> <td> <p> &pound;5m ($7.8m) upfront plus up to &pound;3m ($4.7m) </p> </td> <td><p></td> <td> <p> 7/6/2012 </p> </td> </tr> <tr> <td> <p> <b>LabCorp (US)</b> </p> </td> <td> <p> Medtox Scientific (US) </p> </td> <td> <p> In vitro diagnostics (drugs of abuse and clinical lab testing) </p> </td> <td> <p> $241m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/LabCorp-builds-up-specialty-testing-business-with-Medtox-Scientific-331489?autnID=/contentstore/clinica/codex/c715399b-afd4-11e1-96f7-cb330bbb8023.xml">6/6/2012</a> </p> </td> <td> <p> 1/8/2012 </p> </td> </tr> <tr> <td> <p> <b>Halma (UK)</b> </p> </td> <td> <p> SunTech Medical Group (US) </p> </td> <td> <p> Blood pressure monitoring </p> </td> <td> <p> $50m plus up to $6m milestone payments </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Halma-acquires-blood-pressure-monitoring-firm-SunTech-to-boost-healthcare-offering-331386">1/6/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>MAY</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Maquet Cardiovascular (Germany)</b> </p> </td> <td> <p> Avalon Laboratories' Elite Bi-Caval dual lumen catheter and vascular access kits (US) </p> </td> <td> <p> Extracorporeal life support </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 29/5/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>iTech Medical (US)</b> </p> </td> <td> <p> BIOFlex Medical Magnetics (US) </p> </td> <td> <p> Pain therapy </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/iTech-expands-back-pain-therapy-presence-with-BIOFlex-acquisition-331090?autnID=/contentstore/clinica/codex/ccd9a6fb-a971-11e1-96f7-cb330bbb8023.xml">29/5/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>DaVita (US)</b> </p> </td> <td> <p> HealthCare Partners (US) </p> </td> <td> <p> Integrated care </p> </td> <td> <p> $4.42bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/DaVita-expands-integrated-care-position-with-4.4bn-HealthCare-Partners-buy-330837">22/5/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Agilent Technologies (US)</b> </p> </td> <td> <p> Dako (Denmark) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $2.2bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Agilent-moves-into-companion-diagnostics-with-2.2bn-Dako-buy-330740">18/5/2012</a> </p> </td> <td> <p> 21/6/2012 </p> </td> </tr> <tr> <td> <p> <b>SurgLine International (US)</b> </p> </td> <td> <p> Eden Surgical Technologies (US) </p> </td> <td> <p> Trauma surgical instruments </p> </td> <td> <p> 50 million SurgLine shares </p> </td> <td><p></td> <td> <p> 17/5/2012 </p> </td> </tr> <tr> <td> <p> <b>Straumann (Switzerland)</b> </p> </td> <td> <p> Neodent (Brazil) </p> </td> <td> <p> Dental implants </p> </td> <td> <p> CHF260m ($275m) </p> </td> <td> <p> 16/5/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CryoLife (US)</b> </p> </td> <td> <p> Hemosphere (US) </p> </td> <td> <p> Haemodialysis products (grafts) </p> </td> <td> <p> $17m upfront and $4.5m in milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/CryoLife-looks-to-higher-growth-haemodialysis-products-with-Hemosphere-acquisition-330648?autnID=/contentstore/clinica/codex/01a39ec9-9f6c-11e1-8517-83b041b66bfa.xml">15/5/2012</a> </p> </td> <td> <p> 16/5/2012 </p> </td> </tr> <tr> <td> <p> <b>BC Technical (US)</b> </p> </td> <td> <p> Consus Medical Imaging (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 10/5/2012 </p> </td> </tr> <tr> <td> <p> <b>Smith &amp; Nephew (UK)</b> </p> </td> <td> <p> Kalypto Medical (US) </p> </td> <td> <p> Negative pressure wound therapy devices </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/SandN-boosts-position-in-negative-pressure-wound-therapy-with-Kalypto-acquisition-330324">9/5/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Mindray Medical International (China)</b> </p> </td> <td> <p> Controlling interest in Hangzhou Optcla Medical Instrument (China) </p> </td> <td> <p> Endoscopy </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Mindray-acquires-controlling-stake-in-endoscope-maker-Q1-revenues-grow-21-330286">8/5/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Covidien (US)</b> </p> </td> <td> <p> Maya Medical (US) </p> </td> <td> <p> Renal denervation </p> </td> <td> <p> $60m upfront plus up to $170m milestone payments </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/neurological/Medtronic-and-St-Jude-clash-in-potential-4.4bn-renal-denervation-market-331063?autnID=/contentstore/clinica/codex/f0c2cfdc-a8c8-11e1-96f7-cb330bbb8023.xml">28/5/2012</a> </p> </td> <td> <p> 20/4/2012 </p> </td> </tr> <tr> <td> <p> <b>Johnson &amp; Johnson (US)</b> </p> </td> <td> <p> Guangzhou Bioseal Biotechnology (China) </p> </td> <td> <p> Haemostasis (fibrin sealants to prevent bleeding during surgery) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/JandJ-bolsters-emerging-markets-presence-with-first-Chinese-acquisition-330203">4/5/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Qiagen (the Netherlands)</b> </p> </td> <td> <p> AmniSure International (US) </p> </td> <td> <p> Point-of-need testing (rupture of foetal membranes during pregnancy) </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Qiagen-invests-in-womens-health-and-point-of-need-testing-with-AmniSure-buy-330190">4/5/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Royal DSM (the Netherlands)</b> </p> </td> <td> <p> Kensey Nash (US) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> $360m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/DSM-buys-Kensey-Nash-for-360m-to-bump-up-biomaterials-business-330139?autnID=/contentstore/clinica/codex/9f080c14-9537-11e1-8517-83b041b66bfa.xml">4/5/2012</a> </p> </td> <td> <p> 25/6/2012 </p> </td> </tr> <tr> <td> <p> <b>Teleflex (US)</b> </p> </td> <td> <p> EZ-Blocker technology from IQ Medical Venture (US) </p> </td> <td> <p> Minimally-invasive surgery products (tissue closure devices) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Teleflex-broadens-surgery-offering-with-two-acquisitions-swings-to-Q1-loss-330096?autnID=/contentstore/clinica/codex/5b8431a5-9514-11e1-8517-83b041b66bfa.xml">3/5/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Teleflex (US)</b> </p> </td> <td> <p> Axiom Technology Partners (US) </p> </td> <td> <p> Patient monitoring (measuring intra-abdominal pressure) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Teleflex-broadens-surgery-offering-with-two-acquisitions-swings-to-Q1-loss-330096?autnID=/contentstore/clinica/codex/5b8431a5-9514-11e1-8517-83b041b66bfa.xml">3/5/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Covidien (US)</b> </p> </td> <td> <p> PolyTouch Medical (Israel) </p> </td> <td> <p> Hernia mesh placement products </p> </td> <td> <p> Believed to be $30-40m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Covidiens-strong-Q2-builds-on-good-start-to-2012-acquires-hernia-device-firm-329959?autnID=/contentstore/clinica/codex/4db81258-9393-11e1-bbf2-b7369386e0bb.xml">2/5/2012</a> </p> </td> <td> <p> 2011 </p> </td> </tr> <tr> <td> <p> <b>Baxter International (US)</b> </p> </td> <td> <p> Sigma International General Medical Apparatus (US) </p> </td> <td> <p> Infusion pumps </p> </td> <td> <p> $90m (on top of $100m for 40% equity in 2009) </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Baxter-buys-out-long-time-partner-Sigma-to-gain-infusion-pump-tech-329954?autnID=/contentstore/clinica/codex/9f7b05b8-9372-11e1-bbf2-b7369386e0bb.xml">1/5/2012</a> </p> </td> </tr> <tr> <td> <p> <b>ConvaTec (US)</b> </p> </td> <td> <p> AbViser Medical (US) </p> </td> <td> <p> Patient monitoring (measuring intra-abdominal pressure) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/5/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Hologic (US)</b> </p> </td> <td> <p> Gen-Probe (US) </p> </td> <td> <p> In vitro diagnostics, focused on sexually-transmitted diseases </p> </td> <td> <p> $3.7bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Hologics-3.7bn-Gen-Probe-bid-to-strengthen-womens-health-Dx-offering-329939?autnID=/contentstore/clinica/codex/67f0d615-92e8-11e1-bbf2-b7369386e0bb.xml">1/5/2012</a> </p> </td> <td> <p> 1/8/2012 </p> </td> </tr> <tr> <td> <p> <b>Haemonetics (US)</b> </p> </td> <td> <p> Hemerus Medical (US) </p> </td> <td> <p> Blood transfusion/collection products </p> </td> <td> <p> $27m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/There-will-be-blood-Haemonetics-turns-one-stop-blood-shop-with-Pall-and-Hemerus-deals-329924?autnID=/contentstore/clinica/codex/80173dbf-92dd-11e1-bbf2-b7369386e0bb.xml">1/5/2012</a> </p> </td> <td> <p> 1/5/13 </p> </td> </tr> <tr> <td> <p> <b>Haemonetics (US)</b> </p> </td> <td> <p> Pall's transfusion medicine business (US) </p> </td> <td> <p> Blood transfusion/collection products </p> </td> <td> <p> $551m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/There-will-be-blood-Haemonetics-turns-one-stop-blood-shop-with-Pall-and-Hemerus-deals-329924?autnID=/contentstore/clinica/codex/80173dbf-92dd-11e1-bbf2-b7369386e0bb.xml">1/5/2012</a> </p> </td> <td> <p> 1/8/2012 </p> </td> </tr> <tr> <td> <p> <b>APRIL</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Water Street Healthcare Partners (US)</b> </p> </td> <td> <p> Orthofix International's Breg subsidiary (US) </p> </td> <td> <p> Sports medicine </p> </td> <td> <p> $157.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Breg-sale-lightens-Orthofixs-debt-load-as-it-sets-out-for-spine-and-ortho-growth-329785?autnID=/contentstore/clinica/codex/e7cb3755-8ef2-11e1-bbf2-b7369386e0bb.xml">26/4/2012</a> </p> </td> <td> <p> 24/5/2012 </p> </td> </tr> <tr> <td> <p> <b>Mitsubishi (Japan)</b> </p> </td> <td> <p> 80% stake in Kobayashi Medical (Japan) </p> </td> <td> <p> Medical devices including orthopaedics, surgery and anaesthesiology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Mitsubishi-gets-knee-up-into-new-medtech-segments-with-Kobayashi-Medical-stake-329783?autnID=/contentstore/clinica/codex/9d3d9243-8edd-11e1-bbf2-b7369386e0bb.xml">26/4/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Natus (US)</b> </p> </td> <td> <p> Carefusion's Nicolet neurodiagnostic business (US) </p> </td> <td> <p> Neurodiagnostics including EEG, EMG </p> </td> <td> <p> $58m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/neurological/Natus-fleshes-out-neurology-unit-as-slimming-CareFusion-offloads-Nicolet-329704?autnID=/contentstore/clinica/codex/59cc254d-8e04-11e1-bbf2-b7369386e0bb.xml">25/4/2012</a> </p> </td> <td> <p> 2/7/2012 </p> </td> </tr> <tr> <td> <p> <b>BioTime and subsidiary LifeMap Sciences (US)</b> </p> </td> <td> <p> XenneX (US) </p> </td> <td> <p> Bioinformatics - XenneX has database of human genes </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 23/4/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Riemser Arzneimittel (Germany)</b> </p> </td> <td> <p> 49% stake in Anwerina (Switzerland) </p> </td> <td> <p> Drugs and devices for osteoporotic and traumatic musculoskeletal diseases </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 23/4/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Numera (US)</b> </p> </td> <td> <p> BlueLibris (US) </p> </td> <td> <p> Telecare/telehealth </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 19/04/2012 </p> </td> </tr> <tr> <td> <p> <b>Piramal Healthcare (India)</b> </p> </td> <td> <p> Bayer's (Germany) molecular imaging R&amp;D portfolio </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Piramal-strings-another-RandD-pearl-with-Bayer-PET-tracer-deal-329433?autnID=/contentstore/clinica/codex/59192a3b-88a8-11e1-9497-ad152d0bfb07.xml">18/04/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Beckman Coulter Life Sciences (US)</b> </p> </td> <td> <p> Blue Ocean Medical (US) </p> </td> <td> <p> Flow cytometry </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Beckman-Coulter-looks-to-emerging-flow-cytometry-markets-with-Blue-Ocean-buy-329410?autnID=/contentstore/clinica/codex/2ce78050-8891-11e1-9497-ad152d0bfb07.xml">17/04/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Shire (UK)</b> </p> </td> <td> <p> Pervasis Therapeutics (US) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> Undisclosed - thought to be around $200m upfront plus milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Shire-acquires-Pervasis-Therapeutics-329274?autnID=/contentstore/clinica/codex/80e5324d-8544-11e1-9497-ad152d0bfb07.xml">13/04/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Genstar Capital (US)</b> </p> </td> <td> <p> eResearchTechnology (US) </p> </td> <td> <p> Medical device and diagnostics research </p> </td> <td> <p> $400m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Genstar-Capital-adds-to-clinical-portfolio-with-400m-ERT-buy-329229?autnID=/contentstore/clinica/codex/a54ded6e-8485-11e1-9497-ad152d0bfb07.xml">12/04/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Corning (US)</b> </p> </td> <td> <p> Becton Dickinson's Discovery Labware unit, excluding Advanced Bioprocessing platform (US) </p> </td> <td> <p> Laboratory products including labware and cell culture products </p> </td> <td> <p> $730m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Becton-Dickinson-offloads-Discovery-Labware-unit-as-it-shifts-focus-to-instrumentation-329182?autnID=/contentstore/clinica/codex/e7689698-83d1-11e1-9497-ad152d0bfb07.xml">11/04/2012</a> </p> </td> <td> <p> 1/11/2012 </p> </td> </tr> <tr> <td> <p> <b>Bruker (US)</b> </p> </td> <td> <p> SkyScan (Belgium) </p> </td> <td> <p> 3D X-ray imaging </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Bruker-goes-3D-with-acquisition-of-X-ray-firm-SkyScan-329125?autnID=/contentstore/clinica/codex/2a90d40a-8312-11e1-9497-ad152d0bfb07.xml">10/04/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Cook Medical (US)</b> </p> </td> <td> <p> General BioTechnology (US) </p> </td> <td> <p> Cell and tissue banking and cryopreservation </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 09/04/2012 </p> </td> </tr> <tr> <td> <p> <b>DaVita (US)</b> </p> </td> <td> <p> Controlling interest in Lehbi Care (Saudi Arabia) </p> </td> <td> <p> Kidney care clincs </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 05/04/2012 </p> </td> </tr> <tr> <td> <p> <b>Covidien (US)</b> </p> </td> <td> <p> Oridion Systems (US and Israel) </p> </td> <td> <p> Ventilation monitoring </p> </td> <td> <p> $300m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Covidien-pumps-up-oximeter-portfolio-with-Oridion-buy-329065?autnID=/contentstore/clinica/codex/feb449af-7f1e-11e1-9497-ad152d0bfb07.xml">05/04/2012</a> </p> </td> <td> <p> 26/6/2012 </p> </td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> SeqWright (US) </p> </td> <td> <p> Gene sequencing </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/GE-expands-into-next-gen-sequencing-with-SeqWright-buy-329063?autnID=/contentstore/clinica/codex/2182826f-7f14-11e1-9497-ad152d0bfb07.xml">05/04/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Ethicon (J&amp;J subsidiary, US)</b> </p> </td> <td> <p> AngioTech (Canada) </p> </td> <td> <p> Quill intellectual property &ndash; wound closure </p> </td> <td> <p> $20m plus milestones </p> </td> <td> <p> 04/04/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Biomet (US)</b> </p> </td> <td> <p> J&amp;J's trauma unit (part of DePuy Orthopaedics, US) </p> </td> <td> <p> Orthopaedics (trauma) </p> </td> <td> <p> $280m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/JandJ-offloads-DePuy-trauma-unit-to-Biomet-to-smooth-way-for-Synthes-328942?autnID=/contentstore/clinica/codex/7e6f689d-7dad-11e1-9497-ad152d0bfb07.xml">03/04/2012</a> </p> </td> <td> <p> 15/6/2012 </p> </td> </tr> <tr> <td> <p> <b>SK Capital (US)</b> </p> </td> <td> <p> IBA's molecular division (Belgium) </p> </td> <td> <p> Imaging agents </p> </td> <td> <p> &euro;74.7m ($92.0m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/IBA-back-on-track-to-offload-molecular-imaging-biz-and-focus-on-proton-therapy-332651?autnID=/contentstore/clinica/codex/9c541376-ca9c-11e1-b604-af25a6688b21.xml">2/4/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Derma Sciences (US)</b> </p> </td> <td> <p> MedEfficiency (US) </p> </td> <td> <p> Wound care </p> </td> <td> <p> $14.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Derma-Sciences-expands-wound-care-offering-with-MedEfficiency-acquisition-328844?autnID=/contentstore/clinica/codex/d9172d05-7ccd-11e1-9497-ad152d0bfb07.xml">02/04/2012</a> </p> </td> <td> <p> 17/04/2012 </p> </td> </tr> <tr> <td> <p> <b>MARCH</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>HeartWare International (US)</b> </p> </td> <td> <p> WorldHeart (US) </p> </td> <td> <p> Left ventricular assist devices </p> </td> <td> <p> $8m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/HeartWare-aims-to-overtake-Thoratec-with-WorldHeart-buy-328797?autnID=/contentstore/clinica/codex/8fac798e-7a6b-11e1-9497-ad152d0bfb07.xml">30/03/2012</a> </p> </td> <td> <p> 2/8/2012 </p> </td> </tr> <tr> <td> <p> <b>Advanced Accelerator Applications (France)</b> </p> </td> <td> <p> Majority stake in Umbra Medical AG (Germany) </p> </td> <td> <p> Production of PET imaging agents </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/AAA-continues-European-PET-expansion-with-Umbra-and-GE-deals-328561?autnID=/contentstore/clinica/codex/deefc1a3-7757-11e1-ace0-496a524d2b07.xml">26/03/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Abingdon Health (UK)</b> </p> </td> <td> <p> Majority stake in Molecular Vision (UK) </p> </td> <td> <p> Point-of-care diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Abingdon-buys-stake-in-Molecular-Vision-with-3m-financing-will-shop-for-more-targets-328541?autnID=/contentstore/clinica/codex/7d20b2f8-6df7-11e1-ab65-4737e25c5eed.xml">26/03/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Covidien (US)</b> </p> </td> <td> <p> Newport Medical Instruments </p> </td> <td> <p> Ventilators </p> </td> <td> <p> $108m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Newport-buy-to-help-Covidien-breeze-into-mid-priced-ventilation-market-328522?autnID=/contentstore/clinica/codex/62178f42-74fb-11e1-ab65-4737e25c5eed.xml">23/03/2012</a> </p> </td> <td> <p> 1/05/2012 </p> </td> </tr> <tr> <td> <p> <b>Synergy Health (UK)</b> </p> </td> <td> <p> MSI Surgical Solutions </p> </td> <td> <p> Hospital sterilisation services </p> </td> <td> <p> $6.5m </p> </td> <td><p></td> <td> <p> 21/03/2012 </p> </td> </tr> <tr> <td> <p> <b>Grifols (Spain)</b> </p> </td> <td> <p> Araclon Biotech (Spain) </p> </td> <td> <p> Alzheimer's disease vaccine and diagnostic </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Grifols-saves-Spanish-Alzheimers-vaccine-and-Dx-developer-Araclon-328301?autnID=/contentstore/clinica/codex/f37719f8-727e-11e1-ab65-4737e25c5eed.xml">20/03/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Covidien (US)</b> </p> </td> <td> <p> superDimension (Israel) </p> </td> <td> <p> Pulmonary devices </p> </td> <td> <p> $300m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Covidien-blows-300m-on-superDimension-buy-328282?autnID=/contentstore/clinica/codex/f7b07c6a-71ea-11e1-ab65-4737e25c5eed.xml">20/03/2012</a> </p> </td> <td> <p> 15/05/2012 </p> </td> </tr> <tr> <td> <p> <b>Synergy Health (UK)</b> </p> </td> <td> <p> Leoni Studer Hard (Switzerland) </p> </td> <td> <p> Irradiation sterilisation service provider to medtech, pharma and packaging industries </p> </td> <td> <p> &euro;47.6m ($63.0m) </p> </td> <td> <p> 19/03/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sanofi (France)</b> </p> </td> <td> <p> Pluromed (US) </p> </td> <td> <p> Biosurgery </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Sanofi-strengthens-biosurgery-offering-with-Pluromed-acquisition-328228?autnID=/contentstore/clinica/codex/8546fb39-6f6f-11e1-ab65-4737e25c5eed.xml">16/03/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Masimo (US)</b> </p> </td> <td> <p> Spire Semiconductor (US) </p> </td> <td> <p> Device components </p> </td> <td> <p> $8.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Masimo-to-usher-in-next-gen-patient-monitors-with-8.5m-Spire-buy-328140?autnID=/contentstore/clinica/codex/9c4ef653-6dc9-11e1-ab65-4737e25c5eed.xml">14/03/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Syneron Medical (Israel)</b> </p> </td> <td> <p> TransPharma Medical (Israel) </p> </td> <td> <p> Transdermal drug delivery for aesthetics </p> </td> <td> <p> $3.6m </p> </td> <td> <p> 12/03/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Zynex (US)</b> </p> </td> <td> <p> NeuroDyne Medical (US) </p> </td> <td> <p> Neurological monitoring devices </p> </td> <td> <p> $420,000 </p> </td> <td> <p> 12/03/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Asahi Kasei (Japan)</b> </p> </td> <td> <p> Zoll Medical (US) </p> </td> <td> <p> Automated external defibrillators </p> </td> <td> <p> $2.21bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Japans-Asahi-to-resuscitate-healthcare-business-with-2bn-Zoll-purchase-327974?autnID=/contentstore/clinica/codex/d4e59535-6c4e-11e1-ab65-4737e25c5eed.xml">12/03/2012</a> </p> </td> <td> <p> 23/4/2012 </p> </td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> Cameron Health (US) </p> </td> <td> <p> Cardiac rhythm management (implantable cardioverter defibrillator) </p> </td> <td> <p> $150m upfront plus $150m on approval and up to $1.05bn in milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Boston-aims-to-boost-flagging-CRM-sales-with-1.35bn-buy-of-leadless-ICD-firm-327889?autnID=/contentstore/clinica/codex/df0391bc-69dc-11e1-ab65-4737e25c5eed.xml">09/03/2012</a> </p> </td> <td> <p> 8/6/2012 </p> </td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> Xcellerex (US) </p> </td> <td> <p> Manufacturing technologies for biopharmaceutical industry </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 07/03/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CareFusion (US)</b> </p> </td> <td> <p> PHACTS (US) </p> </td> <td> <p> Medication management </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 06/03/2012 </p> </td> <td> <p> 10/05/2012 </p> </td> </tr> <tr> <td> <p> <b>Varian Medical Systems (US)</b> </p> </td> <td> <p> InfiMed (US) </p> </td> <td> <p> X-ray hardware and software </p> </td> <td> <p> $15m plus milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Varian-expands-diagnostic-offering-with-15m-Infimed-buy-327715">06/03/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Trinity Biotech (Ireland)</b> </p> </td> <td> <p> Fiomi Diagnostics (Sweden) </p> </td> <td> <p> Point-of-care testing </p> </td> <td> <p> $13.1m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Trinity-to-grab-share-of-450m-troponin-testing-market-with-Fiomi-buy-327627?autnID=/contentstore/clinica/codex/1eea4b24-645e-11e1-ad3d-591d2a6db052.xml">02/03/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Alere (US)</b> </p> </td> <td> <p> eScreen (US) </p> </td> <td> <p> Drugs of abuse testing </p> </td> <td> <p> $270m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Alere-to-acquire-workforce-drug-screening-firm-strengthens-toxicology-unit-327552?autnID=/contentstore/clinica/codex/e0ce608f-62f0-11e1-ad3d-591d2a6db052.xml">01/03/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>FEBRUARY</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Orchid Orthopedic Solutions (US)</b> </p> </td> <td> <p> Sandvik (Sweden) </p> </td> <td> <p> Orthopaedic and dental contract manufacturing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Sandvik-bows-out-of-medtech-as-it-offloads-ortho-implant-unit-to-Orchid-327430?autnID=/contentstore/clinica/codex/5ff41136-6164-11e1-ad3d-591d2a6db052.xml">28/02/2012</a> </p> </td> <td> <p> 30/03/2012 </p> </td> </tr> <tr> <td> <p> <b>DexCom (US)</b> </p> </td> <td> <p> SweetSpot Diabetes Care (US) </p> </td> <td> <p> Diabetes blood glucose data management </p> </td> <td> <p> $4.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/DexCom-bags-diabetes-data-management-firm-SweetSpot-for-4.5m-327332">24/02/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Greatbatch (US)</b> </p> </td> <td> <p> NeuroNexus Technologies (US) </p> </td> <td> <p> Neuroscience/ neuromodulation </p> </td> <td> <p> $12m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/neurological/Greatbatch-boosts-neuromodulation-offering-with-12m-NeuroNexus-buy-327184?autnID=/contentstore/clinica/codex/2a2f5ed5-5bd3-11e1-9f3c-c33167de7988.xml">20/02/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Capsalus (US)</b> </p> </td> <td> <p> GeneWize Life Sciences subsidiary of GeneLink Biosciences (US) </p> </td> <td> <p> Consumer genetic testing </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 16/02/2012 </p> </td> </tr> <tr> <td> <p> <b>Becton Dickinson (US)</b> </p> </td> <td> <p> Kiestra Lab Automation (the Netherlands) </p> </td> <td> <p> Microbiology testing automation </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/BD-to-automate-microbiology-testing-with-Kiestra-acquisition-326947">14/02/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Project Plasma (affiliate of Linden Capital Partners, US)</b> </p> </td> <td> <p> SeraCare Life Sciences (US) </p> </td> <td> <p> Life sciences products to facilitate discovery of diagnostics and therapeutics </p> </td> <td> <p> $82m </p> </td> <td> <p> 13/2/2012 </p> </td> <td> <p> 24/4/2012 </p> </td> </tr> <tr> <td> <p> <b>Cardionet (US)</b> </p> </td> <td> <p> ECG Scanning &amp; Medical Services (US) </p> </td> <td> <p> Cardiac monitoring services </p> </td> <td> <p> $5.8m </p> </td> <td><p></td> <td> <p> 10/02/2012 </p> </td> </tr> <tr> <td> <p> <b>Syneron Medical (Israel)</b> </p> </td> <td> <p> Ultrashape Medical (Israel) </p> </td> <td> <p> Cosmetic surgery (fat cell destruction and body sculpting) </p> </td> <td> <p> $12m </p> </td> <td> <p> 08/02/2012 </p> </td> <td> <p> 02/03/2012 </p> </td> </tr> <tr> <td> <p> <b>Two unnamed buyers</b> </p> </td> <td> <p> Wound Management Technologies' Secure eHealth subsidiary (US) </p> </td> <td> <p> Telemedicine </p> </td> <td> <p> $500,000 </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Wound-Management-Technologies-divests-e-health-business-to-focus-on-wound-care-326750">08/02/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Merit Medical Systems (US)</b> </p> </td> <td> <p> Ostial Solutions (US) </p> </td> <td> <p> Stent placement systems </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Merit-in-stent-placement-as-it-acquires-Ostial-326634">06/02/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Canon Europe (UK)</b> </p> </td> <td> <p> Delft Diagnostic Imaging (the Netherlands) </p> </td> <td> <p> Diagnostic imaging and informatics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Canon-enters-medical-informatics-with-Delft-acquisition-326592?autnID=/contentstore/clinica/codex/1c382ab6-4e62-11e1-9f05-17a14a639728.xml">03/02/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>AngioDynamics (US)</b> </p> </td> <td> <p> Navilyst Medical (US) </p> </td> <td> <p> Vascular access products </p> </td> <td> <p> $372m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/AngioDynamics-sees-double-with-Navilyst-buy-326477">01/02/2012</a> </p> </td> <td> <p> 22/5/2012 </p> </td> </tr> <tr> <td> <p> <b>JANUARY </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> </tr> <tr> <td> <p> <b>Smith &amp; Nephew (UK)</b> </p> </td> <td> <p> Aderma range from Focus Product Development (UK) </p> </td> <td> <p> Dermal pads </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 30/01/2012 </p> </td> </tr> <tr> <td> <p> <b>Bruker AXS (US)</b> </p> </td> <td> <p> MICROcaliX product line from Hecus X-ray Systems (Germany) </p> </td> <td> <p> X-ray instrumentation </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 26/01/2012 </p> </td> </tr> <tr> <td> <p> <b>Simbionix (Israel)</b> </p> </td> <td> <p> Arthro VR product line from GMV (Spain) </p> </td> <td> <p> Arthroscopic surgery simulators </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> 25/01/2012 </p> </td> </tr> <tr> <td> <p> <b>Terumo Americas (US)</b> </p> </td> <td> <p> Onset Medical (US) </p> </td> <td> <p> Sheaths for minimally-invasive surgery, eg TAVI </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Terumo-gains-new-minimally-invasive-sheath-tech-with-Onset-acquisition-325919">17/01/2012</a> </p> </td> </tr> <tr> <td> <p> <b>Zimmer (US)</b> </p> </td> <td> <p> Synvasive Technology (US) </p> </td> <td> <p> Patient-specific knee implants </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Zimmer-buys-Synvasive-to-strengthen-patient-specific-knee-offerings-325822?autnID=/contentstore/clinica/codex/f19b0f4c-3ded-11e1-93c4-6dbe5a318e04.xml&amp;REFID=DLYALT">13/01/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Arriva Medical (US)</b> </p> </td> <td> <p> Direct Diabetic Source (US) </p> </td> <td> <p> Diabetic testing equipment provider </p> </td> <td> <p> $5m </p> </td> <td><p></td> <td> <p> 12/01/2012 </p> </td> </tr> <tr> <td> <p> <b>NSF-DBA (UK, part of NSF International)</b> </p> </td> <td> <p> Pink Associates (UK) </p> </td> <td> <p> Medical device training and consulting </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/01/2012 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>RTI International Metals (US)</b> </p> </td> <td> <p> Remmele Engineering (US) </p> </td> <td> <p> Medical device manufacturing </p> </td> <td> <p> $182.5m ($164.5m in cash and $18m in debt) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Metal-maker-RTI-joins-medtech-fold-by-purchasing-device-manufacturer-Remmele-325802?autnID=/contentstore/clinica/codex/75cae40f-3d34-11e1-93c4-6dbe5a318e04.xml">12/01/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Linde Group (Germany)</b> </p> </td> <td> <p> Air Products (US) </p> </td> <td> <p> Air Product's home care business and other services </p> </td> <td> <p> &euro;590m ($750m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Air-Products-to-sell-European-homecare-operations-to-Linde-for-590m-325620?autnID=/contentstore/clinica/codex/d9644b66-3ad1-11e1-93c4-6dbe5a318e04.xml">10/01/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Quest Diagnostics (US)</b> </p> </td> <td> <p> SED Medical Laboratories (US) </p> </td> <td> <p> Drugs of abuse testing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Quest-to-expand-drugs-of-abuse-lab-testing-offering-with-SED-buy-325503?autnID=/contentstore/clinica/codex/3cc0ddac-385a-11e1-93c4-6dbe5a318e04.xml">06/01/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cutera (US)</b> </p> </td> <td> <p> Iridex (US) </p> </td> <td> <p> Iridex's aesthetic business </p> </td> <td> <p> $5.1m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Iridex-to-focus-on-medtech-following-sale-of-aesthetics-unit-to-Cutera-325427?autnID=/contentstore/clinica/codex/6671e1d9-36e7-11e1-93c4-6dbe5a318e04.xml">04/01/2012</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Essex Woodlands (US/UK)</b> </p> </td> <td> <p> Smith &amp; Nephew's non-core orthobiologics unit (US) </p> </td> <td> <p> Orthobiologics </p> </td> <td> <p> $98m in cash and a $160m five-year note </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/SandN-sells-majority-stake-of-orthobiologics-unit-to-VC-Essex-to-set-up-JV-325354?autnID=/contentstore/clinica/codex/5f4b0cf9-36b5-11e1-93c4-6dbe5a318e04.xml">04/01/2012</a> </p> </td> <td><p></td> </tr> </table> 
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 29

Mergers and Acquisitions 2012
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20160622T191413
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT061175
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 29

Mergers and Acquisitions 2012
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

338727
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T191600Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

b544c28a-f61e-4c3f-a139-320e147af2eb
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T231413Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 14

sitecore\admin
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
